HomeSourcesHow Do I?OverviewHelpLogo
[Return to Search][Focus]
Search Terms: compulsory licensing, AIDS, Africa

[Document List][Expanded List][KWIC][FULL]

[Previous Document] Document 7 of 40. [Next Document]

Copyright 2000 Globe Newspaper Company  
The Boston Globe

 View Related Topics 

August 28, 2000, Monday ,THIRD EDITION

SECTION: OP-ED; Pg. A15

LENGTH: 850 words

HEADLINE: SALIH BOOKER Salih Booker is director of the Africa Policy Information Center in Washington and the Africa Fund in New York.;
USE THE SURPLUS TO FIGHT AIDS

BYLINE: By SALIH BOOKER

BODY:
The recent US proposal to lend Africa $1 billion a year at commercial rates for the purchase of antiviral AIDS drugs is a cruel hoax at best and a vivid example of government-subsidized corporate greed at worst.

The plan aims to protect American pharmaceutical companies threatened by African rights under the World Trade Organization's rules to pursue parallel imports and compulsory licensing of anti-AIDS drugs. In other words, the US government is prepared to push Africa further into debt in order to prevent Africans from getting cheaper drugs from Brazil or India or from licensing local firms to produce generic versions at home.

   African governments already spend more on debt repayment to wealthy nations than on their own countries' health and education combined.

The International AIDS Conference recently held in Durban, South Africa, generated tremendous news coverage as a sort of rediscovery of the AIDS pandemic and convinced the Clinton administration that they needed to do something beyond yet another meager request for additional funding for AIDS programs. Setting up a debt financing program through the Export-Import Bank requires no funding from Congress and offers dramatic headlines because of the price tag.

But the news out of Durban was not new. This was the 13th annual event, and no government can claim that it never saw the AIDS plague coming. Mind-boggling estimates of the spread of HIV were available more than a decade ago. But because Africa has become the epicenter of the pandemic, the world is not yet willing to act.

Africa is facing a deadly plague while prosperous Western countries spend huge amounts of money on finding cures for baldness and obesity. The continent is home to an estimated 80 percent of the world's HIV/AIDS population.

This crisis is a stark reminder of the double standard that has marginalized African lives for the past 500 years and that now divides the world between rich and poor, white and black. At the moment, support from international donors to fight AIDS worldwide is estimated at $300 million a year. An effective budget for prevention alone in Sub-Saharan Africa would require about $3 billion.

Yet as US politicians line up to debate how much of the surplus to spend on tax cuts, the option of allocating a significant part of the surplus to fighting AIDS is not even on the table. Because the victims are predominantly black, the wealthy, predominantly white countries fail to respond with more than token resources.

Almost none of the people affected by AIDS in Africa have access to the life-saving drugs that have brought hope to millions of

patients in the West. This is far more than a health issue: AIDS is wiping out large portions of the work force and crippling national economies. More people may die of AIDS in Africa than died in World War I, World War II, Korea, and Vietnam combined.

Multiple strategies to fight the epidemic are available and can make a dramatic difference even in the worst-affected countries. Prevention strategies, from AIDS education to condom distribution, do work when they are implemented on a large scale. This has been amply shown in countries such as Uganda and Senegal. A comprehensive strategy also requires restoring basic health services, which have been slashed throughout Africa. And it must include steps to promote women's rights and change male attitudes, since a large proportion of AIDS patients in Africa are women infected by men.

Making affordable drugs and treatment available rather than restricting them to patients in rich countries is a moral imperative. It is also essential for prevention. Effective prevention requires public willingness to be tested, but as a South Africa AIDS activist recently remarked, why go to the doctor if you know in advance that the medicine cupboard will be bare?

Cancellation of unpayable debts could enable African countries to dedicate higher proportions of their budgets to combating AIDS. Here again pledges from rich countries are not matched by action when budget decisions are made.

US decision makers have not broken out of the business-as-usual budget process that regards spending on global health as an afterthought at best and any spending on Africa as wasteful. The result is that tens of millions of human beings, overwhelmingly Africans, are written off as expendable.

In this election year, candidates for president and for Congress should consider dedicating a modest 5 percent of the annual budget surplus - approximately $9.5 billion a year - to a global health emergency fund. This would still fall short of the effort needed, but it would be a leap above the paltry $325 million in President Clinton's current request to Congress for HIV/AIDS worldwide. And it would send a signal that US politicians share a sense of global responsibility rather than regarding globalization only as an opportunity for corporate profit.

The United States hesitates at its own peril, for the only thing more dangerous to humanity than AIDS itself is the double standard.

LOAD-DATE: August 29, 2000




[Previous Document] Document 7 of 40. [Next Document]


FOCUS

Search Terms: compulsory licensing, AIDS, Africa
To narrow your search, please enter a word or phrase:
   
About Terms and Conditions Top of Page
Copyright© 2001, LEXIS-NEXIS®, a division of Reed Elsevier Inc. All Rights Reserved.